Guizhou Sanli Pharmaceutical's low P/E ratio is potentially ...

Guizhou Sanli Pharmaceutical's low P/E ratio is potentially a result of its expected lower earnings growth compared to the market. Shareholders seem aware of possible lackluster future earnings, possibly affecting the near-term share price.